4-HO-EiBT, also known as 4-hydroxy-N-ethyl-N-isobutyltryptamine or as eibucin, is a substituted tryptamine derivative which acts as a serotonin 5-HT2A receptor agonist, with an EC50Tooltip half-maximal effective concentration of 27.7 nM and an efficacy of 97.5%.[1]

Chemistry

Analogues

Analogues of 4-HO-EiBT include 4-HO-DiPT, 4-HO-DsBT, 4-HO-McPT, 4-HO-McPeT, 4-HO-MiPT, and 4-HO-PiPT, among others.

See also

References

  1. WO 2023/115167, Banister S, Jorgensen W, Jinlong T, "Compounds", published 2023-06-29, assigned to Psylo Pty Ltd.. Retrieved 2025-05-12